304 related articles for article (PubMed ID: 19549095)
1. Persistent parvovirus B19 infection detected by specific CD4+ T-cell responses in a patient with hepatitis and polyarthritis.
Pongratz G; Lindner J; Modrow S; Schimanski S; Schölmerich J; Fleck M
J Intern Med; 2009 Sep; 266(3):296-301. PubMed ID: 19549095
[TBL] [Abstract][Full Text] [Related]
2. CD4(+) T-cell responses against the VP1-unique region in individuals with recent and persistent parvovirus B19 infection.
Lindner J; Barabas S; Saar K; Altmann D; Pfister A; Fleck M; Deml L; Modrow S
J Vet Med B Infect Dis Vet Public Health; 2005; 52(7-8):356-61. PubMed ID: 16316401
[TBL] [Abstract][Full Text] [Related]
3. Human parvovirus B19 infection in patients with chronic hepatitis B or hepatitis C infection.
Hsu TC; Chen TY; Lin MC; Tzang BS; Tsay GJ
J Gastroenterol Hepatol; 2005 May; 20(5):733-8. PubMed ID: 15853987
[TBL] [Abstract][Full Text] [Related]
4. Relevance of B19 markers in serum samples for a diagnosis of parvovirus B19-correlated diseases.
Gallinella G; Zuffi E; Gentilomi G; Manaresi E; Venturoli S; Bonvicini F; Cricca M; Zerbini M; Musiani M
J Med Virol; 2003 Sep; 71(1):135-9. PubMed ID: 12858419
[TBL] [Abstract][Full Text] [Related]
5. Antiphospholipid antibodies in pediatric and adult patients with rheumatic disease are associated with parvovirus B19 infection.
Von Landenberg P; Lehmann HW; Knöll A; Dorsch S; Modrow S
Arthritis Rheum; 2003 Jul; 48(7):1939-47. PubMed ID: 12847688
[TBL] [Abstract][Full Text] [Related]
6. Adaptive immune responses against parvovirus B19 in patients with myocardial disease.
Lindner J; Noutsias M; Lassner D; Wenzel J; Schultheiss HP; Kuehl U; Modrow S
J Clin Virol; 2009 Jan; 44(1):27-32. PubMed ID: 18980860
[TBL] [Abstract][Full Text] [Related]
7. Reconstituted immunity against persistent parvovirus B19 infection in a patient with acquired immunodeficiency syndrome after highly active antiretroviral therapy.
Chen MY; Hung CC; Fang CT; Hsieh SM
Clin Infect Dis; 2001 May; 32(9):1361-5. PubMed ID: 11303273
[TBL] [Abstract][Full Text] [Related]
8. Antibody response to B19 parvovirus VP1 and VP2 linear epitopes in patients with haemophilic arthritis.
Azzi A; Manaresi E; Zakrzewska K; DeSantis R; Musiani M; Zerbini M
J Med Virol; 2004 Apr; 72(4):679-82. PubMed ID: 14981773
[TBL] [Abstract][Full Text] [Related]
9. [Research on Parvovirus B19 infections and chronic articular manifestations in a Tunisian hospital].
Regaya F; Khelifa R; Zouari R; Kchir M; Karoui M; Essid R
Arch Inst Pasteur Tunis; 2003; 80(1-4):9-15. PubMed ID: 15941063
[TBL] [Abstract][Full Text] [Related]
10. Human parvovirus B19 serology and avidity using a combination of recombinant antigens enables a differentiated picture of the current state of infection.
Pfrepper KI; Enders M; Motz M
J Vet Med B Infect Dis Vet Public Health; 2005; 52(7-8):362-5. PubMed ID: 16316402
[TBL] [Abstract][Full Text] [Related]
11. High frequency of parvovirus B19 DNA in bone marrow samples from rheumatic patients.
Lundqvist A; Isa A; Tolfvenstam T; Kvist G; Broliden K
J Clin Virol; 2005 May; 33(1):71-4. PubMed ID: 15797368
[TBL] [Abstract][Full Text] [Related]
12. Parvovirus B19 infection in Chile: markers of infection and immunity in patients with clinical symptoms.
Larrañaga C; León O; Díaz P; Miranda M; Norambuena X; Pérez M; Gaggero A
J Med Virol; 2007 Dec; 79(12):1927-34. PubMed ID: 17935173
[TBL] [Abstract][Full Text] [Related]
13. Parvovirus B19 may have a role in the pathogenesis of juvenile idiopathic arthritis.
Gonzalez B; Larrañaga C; León O; Díaz P; Miranda M; Barría M; Gaggero A
J Rheumatol; 2007 Jun; 34(6):1336-40. PubMed ID: 17477467
[TBL] [Abstract][Full Text] [Related]
14. Parvovirus B19 viral loads in relation to VP1 and VP2 antibody responses in diagnostic blood samples.
Beersma MF; Claas EC; Sopaheluakan T; Kroes AC
J Clin Virol; 2005 Sep; 34(1):71-5. PubMed ID: 15985386
[TBL] [Abstract][Full Text] [Related]
15. Parvovirus B19 infection in patients with rheumatoid arthritis in Taiwan.
Chen YS; Chou PH; Li SN; Tsai WC; Lin KH; Tsai KB; Yen JH; Liu HW
J Rheumatol; 2006 May; 33(5):887-91. PubMed ID: 16511938
[TBL] [Abstract][Full Text] [Related]
16. Chronic fatigue syndrome after human parvovirus B19 infection without persistent viremia.
Seishima M; Mizutani Y; Shibuya Y; Arakawa C
Dermatology; 2008; 216(4):341-6. PubMed ID: 18277075
[TBL] [Abstract][Full Text] [Related]
17. Human parvovirus B19 in patients with aplastic anemia.
Mishra B; Malhotra P; Ratho RK; Singh MP; Varma S; Varma N
Am J Hematol; 2005 Jun; 79(2):166-7. PubMed ID: 15929106
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic of parvovirus B19 infection.
Schwarz TF; Roggendorf M
Behring Inst Mitt; 1990 Aug; (85):35-8. PubMed ID: 2171483
[TBL] [Abstract][Full Text] [Related]
19. Human parvovirus B19 infection during pregnancy--value of modern molecular and serological diagnostics.
Enders M; Schalasta G; Baisch C; Weidner A; Pukkila L; Kaikkonen L; Lankinen H; Hedman L; Söderlund-Venermo M; Hedman K
J Clin Virol; 2006 Apr; 35(4):400-6. PubMed ID: 16332455
[TBL] [Abstract][Full Text] [Related]
20. Intrahepatic long-term persistence of parvovirus B19 and its role in chronic viral hepatitis.
Wang C; Heim A; Schlaphoff V; Suneetha PV; Stegmann KA; Jiang H; Krueger M; Fytili P; Schulz T; Cornberg M; Kandolf R; Manns MP; Bock CT; Wedemeyer H
J Med Virol; 2009 Dec; 81(12):2079-88. PubMed ID: 19856479
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
